Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2025 ▲▼ | Q1 2026 ▲▼ | Change ▲▼ | Q4 2025 ▲▼ | Q1 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Alumis Inc. | 5,779,348 | 5,896,995 | +117,647 | $56.41M | $129.91M | 47.94% | +$73.50M |
| CG Oncology, Inc.(CGON) | 1,004,050 | 1,004,050 | 0 | $41.69M | $67.95M | 25.08% | +$26.27M |
| Disc Medicine, Inc.(IRON) | 299,069 | 374,069 | +75,000 | $23.75M | $23.92M | 8.83% | +$168.9K |
| Hims & Hers Health, Inc.CL A(HIMS) | 273,151 | 738,151 | +465,000 | $8.87M | $15.32M | 5.65% | +$6.45M |
| Eikon Therapeutics, Inc.(EIKN) | 0 | 1,318,983 | +1,318,983 | $0 | $13.95M | 5.15% | +$13.95M |
| Lyell Immunopharma, Inc.(LYEL) | 477,078 | 477,078 | 0 | $14.68M | $9.57M | 3.53% | -$5.11M |
| Pharvaris N.V. COM | 0 | 194,125 | +194,125 | $0 | $5.48M | 2.02% | +$5.48M |
| Nurix Therapeutics, Inc.(NRIX) | 0 | 265,000 | +265,000 | $0 | $4.11M | 1.52% | +$4.11M |
| Maze Therapeutics, Inc.(MAZE) | 86,291 | 25,905 | -60,386 | $3.58M | $773.3K | 0.29% | -$2.80M |
| Natera, Inc.(NTRA) | 67,356 | 0 | -67,356 | $15.43M | $0 | — | -$15.43M |